Ledger.Open graph →
SEC Form D · filed September 1, 2010

AERIE PHARMACEUTICALS INC

Offering
$5.3M
Sold
$5.3M
Exemption
—
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

People & firms on this filing (7)

Thomas J. Van Haarlem · BRIDGEWATER, NJExec · DirectorDavid Epstein · RESEARCH TRIANGLE PARK, NCDirectorThomas J. Van Haarlem · BEDMINSTER, NJExec · DirectorDavid Mack · San Diego, CADirectorDavid Epstein · Newport, RIDirectorGeoffrey Duyk · SAN FRANCISCO, CADirectorJanet Conway · RESEARCH TRIANGLE PARK, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗